NHS National Generic Pharmaceuticals - Transition 2021_2

NHS EnglandcontractContracts FinderRef CF-0206500D0O000000rwimUAA1SME suitablecomplete
View buyer

Estimated value

£2.8m

Awarded value

£2.8m

Awarded 31 Mar 2021

Suppliers

1

Lots

1

1 awarded

Published

07 Jun 2021

Deadline 23 Feb 2021

Other contracts from NHS England· 10

Most recent notices published by the same contracting authority.

View buyer profile →
TitleTypeValuePublished
Matrix - Desk Booking Systemcall off£105k08 May 2026
Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028call off£17k08 May 2026
ID&V Checking Servicecontract£150k08 May 2026
Xerox Managed Print renewal 26/27call off£127k08 May 2026
Manage Engine ServiceDesk Plus Licencescall off£29k08 May 2026
Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026contract£105k08 May 2026
Clinicals Run Maintain Transformcall off£38.0m10 Apr 2026
Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmescontract07 Apr 2026
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiativescontract07 Apr 2026
CPIT System Integration to NHSE RAVScontract£500k01 Apr 2026

Other contracts awarded to Milpharm Ltd/aurobinbdo,Thornton and Ross Ltd,Day Lewis Medical Ltd,Waverley Pharma Europe Limited,Bristol Laboratories Limited,Amarox Limited,Dr.Reddy's Laboratories (UK) Limited,Lexon UK Ltd,Aspire Pharma Limited,Brown & Burk UK Ltd,Morningside Pharmaeuticals,Cipla (EU) Ltd,Ranbaxy UK,Selective Supplies Ltd.,Laboratorio Reig Jofre SA,Accord-UK Ltd,Neon Healthcare Ltd· 0

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →

No related contracts found.